- Home
- BAK vs BBNX Comparison
BAK vs BBNX Comparison
Compare BAK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAK | BBNX |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | BAK | BBNX |
|---|---|---|
| Price | $3.10 | $18.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $4.40 | ★ $29.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,841,708,237.00 | $88,570,000.00 |
| Revenue This Year | N/A | $53.22 |
| Revenue Next Year | $7.81 | $35.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $2.32 | $8.89 |
| 52 Week High | $5.10 | $32.71 |
Technical Indicators
Market Signals| Indicator | BAK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 29.86 |
| Support Level | $3.05 | $16.02 |
| Resistance Level | $3.37 | $32.58 |
| Average True Range (ATR) | 0.13 | 1.83 |
| MACD | 0.03 | -1.51 |
| Stochastic Oscillator | 51.38 | 15.45 |
Price Performance
Historical ComparisonAbout BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.